Total planned funding: $491,748,888
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $178,730,373 |
Mozambique | $73,790,621 |
Zambia | $56,563,172 |
Kenya | $33,360,779 |
Vietnam | $22,206,294 |
South Africa | $15,378,103 |
Botswana | $15,069,117 |
Tanzania | $13,054,729 |
Papua New Guinea | $9,684,080 |
Burundi | $9,307,534 |
Democratic Republic of the Congo | $9,130,245 |
Côte d'Ivoire | $7,979,901 |
Indonesia | $5,431,155 |
India | $5,145,700 |
Uganda | $4,592,442 |
Asia Regional Program | $3,654,954 |
Rwanda | $3,401,414 |
Angola | $3,335,000 |
South Sudan | $2,751,916 |
Ghana | $2,750,000 |
Caribbean Region | $2,717,206 |
Malawi | $2,710,000 |
Eswatini | $2,133,737 |
Ethiopia | $2,053,267 |
Namibia | $1,660,293 |
Central America Region | $1,646,143 |
Haiti | $1,560,713 |
Dominican Republic | $700,000 |
Cameroon | $700,000 |
Central Asia Region | $300,000 |
Lesotho | $250,000 |
Organizational Types
NGO | $491,748,888 |
Program Areas
Care | $158,944,970 |
Treatment | $140,334,645 |
Prevention | $120,268,244 |
Governance and Systems | $39,634,755 |
Testing | $32,566,274 |
Budget Codes
HTXS: Treatment: Adult Treatment | $125,507,224 |
HBHC: Care: Adult Care and Support | $75,886,813 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $62,940,176 |
HKID: Care: Orphans and Vulnerable Children | $57,081,961 |
HVOP: Sexual Prevention: Other Sexual Prevention | $39,300,302 |
HVCT: Testing: HIV Testing and Counseling | $32,566,274 |
PDTX: Treatment: Pediatric Treatment | $14,827,421 |
OHSS: Health Systems Strengthening | $14,670,401 |
HLAB: Laboratory Infrastructure | $14,645,454 |
HVTB: Care: TB/HIV | $14,291,425 |
PDCS: Care: Pediatric Care and Support | $11,684,771 |
HVSI: Strategic Information | $10,318,900 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $7,473,626 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $6,268,382 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $3,536,497 |
HMIN: Biomedical Prevention: Injection Safety | $592,084 |
HMBL: Biomedical Prevention: Blood Safety | $157,177 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$491,748,888
View countries